Rekha Hemrajani Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Rekha Hemrajani.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Rekha Hemrajani. Rekha Hemrajani is in Aravive, Inc. ($ARAV) and President and CEO in Aravive, Inc. ($ARAV) and Director in Adverum Biotechnologies, Inc. ($ADVM) and See Remarks in Arcus Biosciences, Inc. ($RCUS) and Director in ALX ONCOLOGY HOLDINGS INC ($ALXO).
Latest Insider Trading Transactions of Rekha Hemrajani
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADVM, ALXO, ARAV, RCUS
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Hemrajani Rekha | Director | Buy | P | 19.00 | 3,000 | 57,000 | 3,000 | 0 to 3 K |
| Jun 25 2020 | ADVM | Adverum Biotechnol ... | Hemrajani Rekha | Director | Option Exercise | A | 25.64 | 30,000 | 769,200 | 30,000 | |
| Apr 09 2020 | ARAV | Aravive, Inc. | Hemrajani Rekha | Sell | D | 0.00 | 42,750 | 0 | 14,250 | 57 K to 14.3 K (-75.00 %) | |
| Jan 09 2020 | ARAV | Aravive, Inc. | Hemrajani Rekha | President and CEO | Option Exercise | A | 13.77 | 143,000 | 1,969,110 | 143,000 | |
| Jan 09 2020 | ARAV | Aravive, Inc. | Hemrajani Rekha | President and CEO | Grant | A | 0.00 | 57,000 | 0 | 57,000 | 0 to 57 K |
| Aug 16 2019 | ADVM | Adverum Biotechnol ... | Hemrajani Rekha | Director | Option Exercise | A | 13.41 | 33,750 | 452,588 | 45,000 | |
| Aug 16 2019 | ADVM | Adverum Biotechnol ... | Hemrajani Rekha | Director | Option Exercise | A | 13.41 | 33,750 | 452,588 | 45,000 | |
| Aug 02 2019 | ADVM | Adverum Biotechnol ... | Hemrajani Rekha | Director | Option Exercise | A | 13.41 | 11,250 | 150,863 | 11,250 | |
| May 03 2019 | ADVM | Adverum Biotechnol ... | Hemrajani Rekha | Director | Option Exercise | A | 6.48 | 70,000 | 453,600 | 70,000 | |
| Mar 25 2019 | RCUS | Arcus Biosciences, ... | Hemrajani Rekha | See Remarks | Option Exercise | A | 11.23 | 400,000 | 4,492,000 | 400,000 |
Page: 1